APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiopulmonary Bypass Equipment

Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Selected research

Market Outlook & Growth Opportunities

Global Cardiopulmonary Bypass Equipment Market Outlook and Growth Opportunities 2026

23 December 2025191 pages

Choose your research edition.

Industry ResearchCardiopulmonary Bypass Equipment Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiopulmonary Bypass Equipment Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Cardiopulmonary Bypass Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiopulmonary Bypass Equipment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiopulmonary Bypass Equipment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Global Cardiopulmonary Bypass Equipment key players include Sorin, MAQUET, Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%.

North America is the largest market, with a share over 40%, followed by Europe and Asia (ex. China), both have a share over 40%.

Read the full market overview

In terms of product, Single Roller Pump HLM is the largest segment, with a share over 65%. And in terms of application, the largest application is Cardiac Surgery, followed by Acute Respiratory Failure Treatment, Lung Transplant Operation, etc.

This report provides an overview of the global Cardiopulmonary Bypass Equipment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiopulmonary Bypass Equipment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiopulmonary Bypass Equipment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiopulmonary Bypass Equipment market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiopulmonary Bypass Equipment Segment by Company

Sorin

MAQUET

Medtronic

Terumo

Braile Biomedica

Tianjin Medical

Cardiopulmonary Bypass Equipment Segment by Type

Single Roller Pump Cardiopulmonary Bypass Equipment

Double Roller Pump Cardiopulmonary Bypass Equipment

Cardiopulmonary Bypass Equipment Segment by Application

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Cardiopulmonary Bypass Equipment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cardiopulmonary Bypass Equipment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cardiopulmonary Bypass Equipment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cardiopulmonary Bypass Equipment significant trends, drivers, influence factors in global and regions.

6. To analyze Cardiopulmonary Bypass Equipment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiopulmonary Bypass Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiopulmonary Bypass Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiopulmonary Bypass Equipment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cardiopulmonary Bypass Equipment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiopulmonary Bypass Equipment industry.

Chapter 3: Detailed analysis of Cardiopulmonary Bypass Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cardiopulmonary Bypass Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cardiopulmonary Bypass Equipment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cardiopulmonary Bypass Equipment Industry Trends Table 2. Cardiopulmonary Bypass Equipment Industry Drivers Table 3. Cardiopulmonary Bypass Equipment Industry Opportunities and Challenges Table 4. Cardiopulmonary Bypass Equipment Industry Restraints Table 5. Global Cardiopulmonary Bypass Equipment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cardiopulmonary Bypass Equipment Revenue Share by Company (2021-2026) Table 7. Global Cardiopulmonary Bypass Equipment Sales Volume by Company (Units) & (2021-2026) Table 8. Global Cardiopulmonary Bypass Equipment Sales Volume Share by Company (2021-2026) Table 9. Global Cardiopulmonary Bypass Equipment Average Price (K USD/Unit) of Company (2021-2026) Table 10. Global Cardiopulmonary Bypass Equipment Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cardiopulmonary Bypass Equipment Key Company Manufacturing Base & Headquarters Table 12. Global Cardiopulmonary Bypass Equipment Company, Product Type & Application Table 13. Global Cardiopulmonary Bypass Equipment Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cardiopulmonary Bypass Equipment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Roller Pump Cardiopulmonary Bypass Equipment Table 18. Significant Companies of Double Roller Pump Cardiopulmonary Bypass Equipment Table 19. Global Cardiopulmonary Bypass Equipment Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Cardiopulmonary Bypass Equipment Sales Volume by Type (2021-2026) & (Units) Table 21. Global Cardiopulmonary Bypass Equipment Sales Volume by Type (2027-2032) & (Units) Table 22. Global Cardiopulmonary Bypass Equipment Sales Volume Share by Type (2021-2026) Table 23. Global Cardiopulmonary Bypass Equipment Sales Volume Share by Type (2027-2032) Table 24. Global Cardiopulmonary Bypass Equipment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cardiopulmonary Bypass Equipment Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cardiopulmonary Bypass Equipment Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cardiopulmonary Bypass Equipment Sales Value Share by Type (2021-2026) Table 28. Global Cardiopulmonary Bypass Equipment Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cardiac Surgery Table 30. Significant Companies of Lung Transplant Operation Table 31. Significant Companies of Acute Respiratory Failure Treatment Table 32. Significant Companies of Others Table 33. Global Cardiopulmonary Bypass Equipment Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Cardiopulmonary Bypass Equipment Sales Volume by Application (2021-2026) & (Units) Table 35. Global Cardiopulmonary Bypass Equipment Sales Volume by Application (2027-2032) & (Units) Table 36. Global Cardiopulmonary Bypass Equipment Sales Volume Share by Application (2021-2026) Table 37. Global Cardiopulmonary Bypass Equipment Sales Volume Share by Application (2027-2032) Table 38. Global Cardiopulmonary Bypass Equipment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Cardiopulmonary Bypass Equipment Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Cardiopulmonary Bypass Equipment Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Cardiopulmonary Bypass Equipment Sales Value Share by Application (2021-2026) Table 42. Global Cardiopulmonary Bypass Equipment Sales Value Share by Application (2027-2032) Table 43. Global Cardiopulmonary Bypass Equipment Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Cardiopulmonary Bypass Equipment Sales by Region (2021-2026) & (Units) Table 45. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2021-2026) Table 46. Global Cardiopulmonary Bypass Equipment Sales by Region (2027-2032) & (Units) Table 47. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2027-2032) Table 48. Global Cardiopulmonary Bypass Equipment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Cardiopulmonary Bypass Equipment Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Cardiopulmonary Bypass Equipment Sales Value Share by Region (2021-2026) Table 51. Global Cardiopulmonary Bypass Equipment Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Cardiopulmonary Bypass Equipment Sales Value Share by Region (2027-2032) Table 53. Global Cardiopulmonary Bypass Equipment Market Average Price (K USD/Unit) by Region (2021-2026) Table 54. Global Cardiopulmonary Bypass Equipment Market Average Price (K USD/Unit) by Region (2027-2032) Table 55. Global Cardiopulmonary Bypass Equipment Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Cardiopulmonary Bypass Equipment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Cardiopulmonary Bypass Equipment Sales by Country (2021-2026) & (Units) Table 58. Global Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021-2026) Table 59. Global Cardiopulmonary Bypass Equipment Sales by Country (2027-2032) & (Units) Table 60. Global Cardiopulmonary Bypass Equipment Sales Market Share by Country (2027-2032) Table 61. Global Cardiopulmonary Bypass Equipment Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Cardiopulmonary Bypass Equipment Sales Value Market Share by Country (2021-2026) Table 63. Global Cardiopulmonary Bypass Equipment Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Cardiopulmonary Bypass Equipment Sales Value Market Share by Country (2027-2032) Table 65. Sorin Company Information Table 66. Sorin Business Overview Table 67. Sorin Cardiopulmonary Bypass Equipment Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 68. Sorin Cardiopulmonary Bypass Equipment Product Portfolio Table 69. Sorin Recent Development Table 70. MAQUET Company Information Table 71. MAQUET Business Overview Table 72. MAQUET Cardiopulmonary Bypass Equipment Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 73. MAQUET Cardiopulmonary Bypass Equipment Product Portfolio Table 74. MAQUET Recent Development Table 75. Medtronic Company Information Table 76. Medtronic Business Overview Table 77. Medtronic Cardiopulmonary Bypass Equipment Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 78. Medtronic Cardiopulmonary Bypass Equipment Product Portfolio Table 79. Medtronic Recent Development Table 80. Terumo Company Information Table 81. Terumo Business Overview Table 82. Terumo Cardiopulmonary Bypass Equipment Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 83. Terumo Cardiopulmonary Bypass Equipment Product Portfolio Table 84. Terumo Recent Development Table 85. Braile Biomedica Company Information Table 86. Braile Biomedica Business Overview Table 87. Braile Biomedica Cardiopulmonary Bypass Equipment Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 88. Braile Biomedica Cardiopulmonary Bypass Equipment Product Portfolio Table 89. Braile Biomedica Recent Development Table 90. Tianjin Medical Company Information Table 91. Tianjin Medical Business Overview Table 92. Tianjin Medical Cardiopulmonary Bypass Equipment Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 93. Tianjin Medical Cardiopulmonary Bypass Equipment Product Portfolio Table 94. Tianjin Medical Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Cardiopulmonary Bypass Equipment Distributors List Table 98. Cardiopulmonary Bypass Equipment Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Cardiopulmonary Bypass Equipment Product Image Figure 2. Global Cardiopulmonary Bypass Equipment Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiopulmonary Bypass Equipment Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cardiopulmonary Bypass Equipment Sales (2021-2032) & (Units) Figure 5. Global Cardiopulmonary Bypass Equipment Sales Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Cardiopulmonary Bypass Equipment Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Roller Pump Cardiopulmonary Bypass Equipment Image Figure 10. Double Roller Pump Cardiopulmonary Bypass Equipment Image Figure 11. Global Cardiopulmonary Bypass Equipment Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Cardiopulmonary Bypass Equipment Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cardiopulmonary Bypass Equipment Sales Volume Share by Type (2021-2032) Figure 14. Global Cardiopulmonary Bypass Equipment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cardiopulmonary Bypass Equipment Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cardiopulmonary Bypass Equipment Sales Value Share by Type (2021-2032) Figure 17. Cardiac Surgery Image Figure 18. Lung Transplant Operation Image Figure 19. Acute Respiratory Failure Treatment Image Figure 20. Others Image Figure 21. Global Cardiopulmonary Bypass Equipment Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Cardiopulmonary Bypass Equipment Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Cardiopulmonary Bypass Equipment Sales Volume Share by Application (2021-2032) Figure 24. Global Cardiopulmonary Bypass Equipment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Cardiopulmonary Bypass Equipment Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Cardiopulmonary Bypass Equipment Sales Value Share by Application (2021-2032) Figure 27. Global Cardiopulmonary Bypass Equipment Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Cardiopulmonary Bypass Equipment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Cardiopulmonary Bypass Equipment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Cardiopulmonary Bypass Equipment Sales Value (2021-2032) & (US$ Million) Figure 32. North America Cardiopulmonary Bypass Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Cardiopulmonary Bypass Equipment Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Cardiopulmonary Bypass Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Cardiopulmonary Bypass Equipment Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Cardiopulmonary Bypass Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Cardiopulmonary Bypass Equipment Sales Value (2021-2032) & (US$ Million) Figure 38. South America Cardiopulmonary Bypass Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Cardiopulmonary Bypass Equipment Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Cardiopulmonary Bypass Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Cardiopulmonary Bypass Equipment Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Cardiopulmonary Bypass Equipment Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Single Roller Pump Cardiopulmonary Bypass Equipment
  • Double Roller Pump Cardiopulmonary Bypass Equipment
Applications
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Companies covered
  • Sorin
  • MAQUET
  • Medtronic
  • Terumo
  • Braile Biomedica
  • Tianjin Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiopulmonary Bypass Equipment Sales Value (2021-2032)
  4. 1.2.2 Global Cardiopulmonary Bypass Equipment Sales Volume (2021-2032)
  5. 1.2.3 Global Cardiopulmonary Bypass Equipment Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cardiopulmonary Bypass Equipment Market Dynamics
  1. 2.1 Cardiopulmonary Bypass Equipment Industry Trends
  2. 2.2 Cardiopulmonary Bypass Equipment Industry Drivers
  3. 2.3 Cardiopulmonary Bypass Equipment Industry Opportunities and Challenges
  4. 2.4 Cardiopulmonary Bypass Equipment Industry Restraints
3 Cardiopulmonary Bypass Equipment Market by Company
  1. 3.1 Global Cardiopulmonary Bypass Equipment Company Revenue Ranking in 2025
  2. 3.2 Global Cardiopulmonary Bypass Equipment Revenue by Company (2021-2026)
  3. 3.3 Global Cardiopulmonary Bypass Equipment Sales Volume by Company (2021-2026)
  4. 3.4 Global Cardiopulmonary Bypass Equipment Average Price by Company (2021-2026)
  5. 3.5 Global Cardiopulmonary Bypass Equipment Company Ranking (2024-2026)
  6. 3.6 Global Cardiopulmonary Bypass Equipment Company Manufacturing Base and Headquarters
  7. 3.7 Global Cardiopulmonary Bypass Equipment Company Product Type and Application
  8. 3.8 Global Cardiopulmonary Bypass Equipment Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cardiopulmonary Bypass Equipment Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cardiopulmonary Bypass Equipment Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cardiopulmonary Bypass Equipment Market by Type
  1. 4.1 Cardiopulmonary Bypass Equipment Type Introduction
  2. 4.1.1 Single Roller Pump Cardiopulmonary Bypass Equipment
  3. 4.1.2 Double Roller Pump Cardiopulmonary Bypass Equipment
  4. 4.2 Global Cardiopulmonary Bypass Equipment Sales Volume by Type
  5. 4.2.1 Global Cardiopulmonary Bypass Equipment Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cardiopulmonary Bypass Equipment Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cardiopulmonary Bypass Equipment Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cardiopulmonary Bypass Equipment Sales Value by Type
  9. 4.3.1 Global Cardiopulmonary Bypass Equipment Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cardiopulmonary Bypass Equipment Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cardiopulmonary Bypass Equipment Sales Value Share by Type (2021-2032)
5 Cardiopulmonary Bypass Equipment Market by Application
  1. 5.1 Cardiopulmonary Bypass Equipment Application Introduction
  2. 5.1.1 Cardiac Surgery
  3. 5.1.2 Lung Transplant Operation
  4. 5.1.3 Acute Respiratory Failure Treatment
  5. 5.1.4 Others
  6. 5.2 Global Cardiopulmonary Bypass Equipment Sales Volume by Application
  7. 5.2.1 Global Cardiopulmonary Bypass Equipment Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cardiopulmonary Bypass Equipment Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Cardiopulmonary Bypass Equipment Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Cardiopulmonary Bypass Equipment Sales Value by Application
  11. 5.3.1 Global Cardiopulmonary Bypass Equipment Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cardiopulmonary Bypass Equipment Sales Value by Application (2021-2032)
  13. 5.3.3 Global Cardiopulmonary Bypass Equipment Sales Value Share by Application (2021-2032)
6 Cardiopulmonary Bypass Equipment Regional Sales and Value Analysis
  1. 6.1 Global Cardiopulmonary Bypass Equipment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiopulmonary Bypass Equipment Sales by Region (2021-2032)
  3. 6.2.1 Global Cardiopulmonary Bypass Equipment Sales by Region: 2021-2026
  4. 6.2.2 Global Cardiopulmonary Bypass Equipment Sales by Region (2027-2032)
  5. 6.3 Global Cardiopulmonary Bypass Equipment Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cardiopulmonary Bypass Equipment Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cardiopulmonary Bypass Equipment Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cardiopulmonary Bypass Equipment Sales Value by Region (2027-2032)
  9. 6.5 Global Cardiopulmonary Bypass Equipment Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cardiopulmonary Bypass Equipment Sales Value (2021-2032)
  12. 6.6.2 North America Cardiopulmonary Bypass Equipment Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cardiopulmonary Bypass Equipment Sales Value (2021-2032)
  15. 6.7.2 Europe Cardiopulmonary Bypass Equipment Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cardiopulmonary Bypass Equipment Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cardiopulmonary Bypass Equipment Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cardiopulmonary Bypass Equipment Sales Value (2021-2032)
  21. 6.9.2 South America Cardiopulmonary Bypass Equipment Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cardiopulmonary Bypass Equipment Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cardiopulmonary Bypass Equipment Sales Value Share by Country, 2025 VS 2032
7 Cardiopulmonary Bypass Equipment Country-level Sales and Value Analysis
  1. 7.1 Global Cardiopulmonary Bypass Equipment Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cardiopulmonary Bypass Equipment Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cardiopulmonary Bypass Equipment Sales by Country (2021-2032)
  4. 7.3.1 Global Cardiopulmonary Bypass Equipment Sales by Country (2021-2026)
  5. 7.3.2 Global Cardiopulmonary Bypass Equipment Sales by Country (2027-2032)
  6. 7.4 Global Cardiopulmonary Bypass Equipment Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cardiopulmonary Bypass Equipment Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cardiopulmonary Bypass Equipment Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cardiopulmonary Bypass Equipment Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cardiopulmonary Bypass Equipment Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cardiopulmonary Bypass Equipment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sorin
  2. 8.1.1 Sorin Company Information
  3. 8.1.2 Sorin Business Overview
  4. 8.1.3 Sorin Cardiopulmonary Bypass Equipment Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sorin Cardiopulmonary Bypass Equipment Product Portfolio
  6. 8.1.5 Sorin Recent Developments
  7. 8.2 MAQUET
  8. 8.2.1 MAQUET Company Information
  9. 8.2.2 MAQUET Business Overview
  10. 8.2.3 MAQUET Cardiopulmonary Bypass Equipment Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MAQUET Cardiopulmonary Bypass Equipment Product Portfolio
  12. 8.2.5 MAQUET Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Cardiopulmonary Bypass Equipment Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Cardiopulmonary Bypass Equipment Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Cardiopulmonary Bypass Equipment Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Cardiopulmonary Bypass Equipment Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Braile Biomedica
  26. 8.5.1 Braile Biomedica Company Information
  27. 8.5.2 Braile Biomedica Business Overview
  28. 8.5.3 Braile Biomedica Cardiopulmonary Bypass Equipment Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Braile Biomedica Cardiopulmonary Bypass Equipment Product Portfolio
  30. 8.5.5 Braile Biomedica Recent Developments
  31. 8.6 Tianjin Medical
  32. 8.6.1 Tianjin Medical Company Information
  33. 8.6.2 Tianjin Medical Business Overview
  34. 8.6.3 Tianjin Medical Cardiopulmonary Bypass Equipment Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Medical Cardiopulmonary Bypass Equipment Product Portfolio
  36. 8.6.5 Tianjin Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cardiopulmonary Bypass Equipment Value Chain Analysis
  2. 9.1.1 Cardiopulmonary Bypass Equipment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cardiopulmonary Bypass Equipment Sales Mode & Process
  6. 9.2 Cardiopulmonary Bypass Equipment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cardiopulmonary Bypass Equipment Distributors
  9. 9.2.3 Cardiopulmonary Bypass Equipment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst